Pharma IQ | 07/15/2010
Dr. Andy Bell, Research Fellow at Sandwich Laboratories Worldwide R&D, Pfizer, shares his insights on Pfizer's review of their screening file, prior to the merger with Wyeth in 2009. He also discusses with Pharma IQ, how they identified areas where improvements could be made to the quality of the collection.
To continue reading this story Click Here
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More